Search Count: 38,523
All
Selected
 |
N-Alkyl & N-Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy To Identify Orally Bioavailable Plasma Kallikrein Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2026-03-11 Classification: HYDROLASE/INHIBITOR Ligands: A1C6O |
 |
N-Alkyl &Amp; N-Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy To Identify Orally Bioavailable Plasmakallikrein Inhibitors Complex With Compound 4 ((3'R)-1'-(5-Amino-1-Benzyl-1H-Pyrazole-4-Carbonyl)-6-Chloro-5-Fluorospiro[[3,1]Benzoxazine-4,3'-Piperidin]-2(1H)-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2026-03-11 Classification: HYDROLASE/INHIBITOR Ligands: MES, A1C6Q, NAG |
 |
N-Alkyl &Amp; N-Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy To Identify Orally Bioavailable Plasma Kallikrein Inhibitors Compound 25 ((3'R)-1'-{(1P)-5-Amino-1-[2-(Trifluoromethoxy)Phenyl]-1H-Pyrazole-4-Carbonyl}-6-Chloro-5-Fluorospiro[[3,1]Benzoxazine-4,3'-Piperidin]-2(1H)-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2026-03-11 Classification: HYDROLASE/INHIBITOR Ligands: MES, A1C6Z, NAG |
 |
N-Alkyl &Amp; N-Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy To Identify Orally Bioavailable Plasma Kallikrein Inhibitors Compound 13 ((3'R)-1'-{5-Amino-1-[(2S)-1,1,1-Trifluorobutan-2-Yl]-1H-Pyrazole-4-Carbonyl}-6-Chloro-5-Fluorospiro[[3,1]Benzoxazine-4,3'-Piperidin]-2(1H)-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-03-11 Classification: HYDROLASE/INHIBITOR Ligands: MES, A1C7M |
 |
Crystal Structure Of Compound 1 Bound To Human Nicotinamide N-Methyltransferase
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.34 Å Release Date: 2026-03-11 Classification: TRANSFERASE Ligands: A1MC7 |
 |
Crystal Structure Of Compound 2 Bound To Human Nicotinamide N-Methyltransferase
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2026-03-11 Classification: TRANSFERASE Ligands: A1MC9 |
 |
Crystal Structure Of Human Inpp5K With An Allosteric Inhibitor Reveals The Structural Basis For Species Specific Potency
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2026-03-11 Classification: TRANSFERASE Ligands: EDO, MLI, A1MDP |
 |
Crystal Structure Of Myst Histone Acetyltransferase Kat6A In Complex With Compound 20
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2026-03-11 Classification: TRANSCRIPTION Ligands: A1MDU |
 |
Crystal Structure Of The Sars-Cov-2 Main Protease In Complex With Covalent Tripeptidyl Inhibitor Nip-22C
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.43 Å Release Date: 2026-03-11 Classification: VIRAL PROTEIN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.96 Å Release Date: 2026-03-11 Classification: ISOMERASE Ligands: A1EBR, 1PG |
 |
Crystal Structure Of Human Pin1 Catalytic Domain In Complex With A Covalent Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.56 Å Release Date: 2026-03-11 Classification: ISOMERASE Ligands: A1EBS, CIT |
 |
Organism: Severe acute respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2026-03-11 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Organism: Human coronavirus nl63
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2026-03-11 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease G15S Mutant In Complex With Ibuzatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2026-03-11 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease K90R Mutant In Complex With Ibuzatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2026-03-11 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease E166N Mutant In Complex With Ibuzatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2026-03-11 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Crystal Structure Of Sars-Cov-2 Main Protease E166R Mutant In Complex With Ibuzatrelvir
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2026-03-11 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Cryo-Em Structure Of Sars-Cov-2 Ba.2.75 Spike Protein Complex With A Potent Broad-Spectrum Macrocyclic Peptide Inhibitor 6L3-3P11K
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2026-03-11 Classification: VIRAL PROTEIN |
 |
Cryo-Em Structure Of Sars-Cov-2 Pt Spike Protein Complex With A Potent Broad-Spectrum Macrocyclic Peptide Inhibitor 6L3-3P11K
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: ELECTRON MICROSCOPY Resolution:2.70 Å Release Date: 2026-03-11 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Crystal Structure Of Human Thymine Dna Glycosylase Tdg In Complex With A Covalent Inhibitor (1S, 5R)-C-2711
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2026-03-11 Classification: DNA BINDING PROTEIN Ligands: A1LYG |